- Home
- TEO vs PTGX Comparison
TEO vs PTGX Comparison
Compare TEO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEO
- PTGX
- Stock Information
- Founded
- TEO 1979
- PTGX 2006
- Country
- TEO Argentina
- PTGX United States
- Employees
- TEO N/A
- PTGX N/A
- Industry
- TEO Telecommunications Equipment
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- TEO Telecommunications
- PTGX Health Care
- Exchange
- TEO Nasdaq
- PTGX Nasdaq
- Market Cap
- TEO 3.9B
- PTGX 3.3B
- IPO Year
- TEO N/A
- PTGX 2016
- Fundamental
- Price
- TEO $9.02
- PTGX $58.97
- Analyst Decision
- TEO Sell
- PTGX Strong Buy
- Analyst Count
- TEO 2
- PTGX 8
- Target Price
- TEO $10.60
- PTGX $70.13
- AVG Volume (30 Days)
- TEO 181.2K
- PTGX 646.3K
- Earning Date
- TEO 08-11-2025
- PTGX 08-06-2025
- Dividend Yield
- TEO 2.26%
- PTGX N/A
- EPS Growth
- TEO N/A
- PTGX N/A
- EPS
- TEO N/A
- PTGX 0.80
- Revenue
- TEO $4,338,754,502.00
- PTGX $209,180,000.00
- Revenue This Year
- TEO $51.39
- PTGX N/A
- Revenue Next Year
- TEO $6.66
- PTGX $185.11
- P/E Ratio
- TEO N/A
- PTGX $73.40
- Revenue Growth
- TEO 11.12
- PTGX N/A
- 52 Week Low
- TEO $6.60
- PTGX $33.31
- 52 Week High
- TEO $15.54
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- TEO 45.90
- PTGX 57.69
- Support Level
- TEO $8.42
- PTGX $55.26
- Resistance Level
- TEO $9.81
- PTGX $58.79
- Average True Range (ATR)
- TEO 0.51
- PTGX 2.20
- MACD
- TEO -0.12
- PTGX 0.39
- Stochastic Oscillator
- TEO 26.55
- PTGX 66.84
About TEO Telecom Argentina SA
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company provides services in Argentina (mobile, cable television, Internet and fixed and data services), Paraguay (mobile, Internet and satellite TV services), Uruguay (cable television services), the United States (fixed wholesale services) and Chile (Cybersecurity services and products).
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.